Metoprolol Succinate
Metoprolol Succinate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Metoprolol Succinate; Generic name: METOPROLOL SUCCINATE; Manufacturer: Preferred Pharmaceuticals Inc.
| Brand name | Metoprolol Succinate |
|---|---|
| Generic name | METOPROLOL SUCCINATE |
| Manufacturer | Preferred Pharmaceuticals Inc |
| Used for | 1 INDICATIONS & USAGE Metoprolol succinate extended-release tablets, metoprolol succinate, beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.() • Angina Pectoris. () • Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure() 1.1 Hypertension Metoprolol succinate extended-release tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, p |
| Dosage | 2 DOSAGE & ADMINISTRATION Metoprolol succinate extended-release tablets are extended-release tablets intended for once daily administration. For treatment of hypertension and angina, when switching from immediate-release metoprolol to metoprolol succinate extended-release tablets, use the same total daily dose of metoprolol succinate extended-release tablets. Individualize the dosage of metoprolol succinate extended-release tablets. Titration may be needed in some patients. Metoprolol succinate |
| Active ingredient(s) | METOPROLOL TARTRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ded3105-b962-4748-bf5b-fca7a4557562 |